169 related articles for article (PubMed ID: 37079124)
41. ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
Chen XY; Wen XM; Zhao W; Chu MQ; Gu Y; Huang HH; Yuan Q; Xu ZJ; Qian J; Lin J
Discov Oncol; 2023 Nov; 14(1):210. PubMed ID: 37994961
[TBL] [Abstract][Full Text] [Related]
42. [HECTD2 Represses Cell Proliferation in Colorectal Cancer through Driving Ubiquitination and Degradation of LPCAT1].
Ma L; Li DH; Xu Z
Mol Biol (Mosk); 2022; 56(4):574-584. PubMed ID: 35964314
[TBL] [Abstract][Full Text] [Related]
43. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
44. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
[TBL] [Abstract][Full Text] [Related]
45. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
46. Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Abdelzaher Ahmed E; Abdel Bary Abdel-Latif A; Fahmy AM; Elzarrouk Mania I
J Histotechnol; 2021 Dec; 44(4):196-205. PubMed ID: 34378492
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.
Zhang J; Zhou J; Tang X; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Qian J; Deng ZQ
Oncotarget; 2017 Nov; 8(54):92536-92544. PubMed ID: 29190935
[TBL] [Abstract][Full Text] [Related]
50. Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.
Nan FY; Gu Y; Xu ZJ; Sun GK; Zhou JD; Zhang TJ; Ma JC; Leng JY; Lin J; Qian J
Cancer Med; 2021 Aug; 10(15):5283-5296. PubMed ID: 34227248
[TBL] [Abstract][Full Text] [Related]
51. Molecular mechanisms regulating lysophosphatidylcholine acyltransferase 1 (LPCAT1) in human pregnancy.
Purandare N; Minchella P; Somayajulu M; Kramer KJ; Zhou J; Adekoya N; Welch RA; Grossman LI; Aras S; Recanati MA
Placenta; 2021 Mar; 106():40-48. PubMed ID: 33618181
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
53. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
54. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
Wang Z; Hong Z; Gao F; Feng W
Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342
[TBL] [Abstract][Full Text] [Related]
55. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
56. MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
Xu Y; Li K; Wang SB; Yang SG
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1610-1619. PubMed ID: 30840284
[TBL] [Abstract][Full Text] [Related]
57. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
58. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
Lin X; Wang Z; Zhang R; Feng W
Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
[TBL] [Abstract][Full Text] [Related]
59. LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments.
Chen ZX; Liang L; Huang HQ; Li JD; He RQ; Huang ZG; Song R; Chen G; Li JJ; Cai ZW; Huang JA
Cancer Med; 2023 Jun; 12(12):13438-13454. PubMed ID: 37184260
[TBL] [Abstract][Full Text] [Related]
60. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
